Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
5 Patents
#107 in Amsterdam
#1,131 in Netherlands
Kling Biotherapeutics B.v.
Forward Citations = 0
15 inventors:
Kling Biotherapeutics B.v.
Calculating rank
EPO Patents = 1
Forward Citations = 0
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Hergen Spits (5 out of 26 patents)
Paula Maria Wilhelmina Van Helden (3 out of 4 patents)
Martijn Kedde (3 out of 4 patents)
4. Tim Beaumont (3 out of 30 patents)
5. Wouter Pos (2 out of 3 patents)
6. Mark Jeroen Kwakkenbos (2 out of 18 patents)
7. Marijn Aletta Gillissen (2 out of 3 patents)
8. Mette Deborah Hazenberg (2 out of 3 patents)
9. Remko Schotte (1 out of 3 patents)
10. Christien Fatmawati (1 out of 2 patents)
11. Danïel Michiel Go (1 out of 2 patents)
12. Julien Christian Villaudy (1 out of 2 patents)
13. Koen Wagner (1 out of 5 patents)
14. Adrianus Quirinus Bakker (1 out of 16 patents)
15. Sabrina Julia Louisa Merat (1 out of 1 patent)
5 patents:
Company Overview
Kling Biotherapeutics B.v. is a biotechnology company dedicated to developing innovative therapies for cancer. Our team of experts is focused on advancing cutting-edge research in immuno-oncology to improve patient outcomes. With a passion for science and a commitment to excellence, Kling Biotherapeutics is driven to make a meaningful impact in the fight against cancer.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kling Biotherapeutics B.v.. Retrieved from https://idiyas.com/company/kling-biotherapeutics-b-v
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]